{"status":"OK","data":{"id":2723742,"identifier":"DVN/SNCLKL","persistentUrl":"https://doi.org/10.7910/DVN/SNCLKL","protocol":"doi","authority":"10.7910","publisher":"Harvard Dataverse","publicationDate":"2016-03-10","storageIdentifier":"s3://dvn-cloud:10.7910/DVN/SNCLKL","latestVersion":{"id":77868,"storageIdentifier":"s3://dvn-cloud:10.7910/DVN/SNCLKL","versionNumber":1,"versionMinorNumber":0,"versionState":"RELEASED","productionDate":"Production Date","lastUpdateTime":"2016-03-10T09:20:27Z","releaseTime":"2016-03-10T09:20:27Z","createTime":"2015-11-10T10:44:00Z","license":"CC0","termsOfUse":"CC0 Waiver","metadataBlocks":{"citation":{"displayName":"Citation Metadata","fields":[{"typeName":"title","multiple":false,"typeClass":"primitive","value":"Labcode 12- HIV neutralization Protocol Recombinant Viruses in HEK-293T"},{"typeName":"author","multiple":true,"typeClass":"compound","value":[{"authorName":{"typeName":"authorName","multiple":false,"typeClass":"primitive","value":"Jose Alcami"},"authorAffiliation":{"typeName":"authorAffiliation","multiple":false,"typeClass":"primitive","value":"Istitute de Salud Carlos III, Spain"}}]},{"typeName":"datasetContact","multiple":true,"typeClass":"compound","value":[{"datasetContactName":{"typeName":"datasetContactName","multiple":false,"typeClass":"primitive","value":"Jose Alcami"},"datasetContactAffiliation":{"typeName":"datasetContactAffiliation","multiple":false,"typeClass":"primitive","value":"Istitute de Salud Carlos III, Spain"},"datasetContactEmail":{"typeName":"datasetContactEmail","multiple":false,"typeClass":"primitive","value":"ppalcami@isciii.es"}}]},{"typeName":"dsDescription","multiple":true,"typeClass":"compound","value":[{"dsDescriptionValue":{"typeName":"dsDescriptionValue","multiple":false,"typeClass":"primitive","value":"This document contained a protocol on HIV neutralization utilizing recombinant viruses in HEK-293T cells.Transfection efficiency is monitored by quantifying luciferase expression. Viral supernatants are titrated in U87.CD4-CCR5/CXCR4 cells depending on envelope tropism of the recombinant virus. "}}]},{"typeName":"subject","multiple":true,"typeClass":"controlledVocabulary","value":["Medicine, Health and Life Sciences"]},{"typeName":"depositor","multiple":false,"typeClass":"primitive","value":"sheik-khalil, enas"},{"typeName":"dateOfDeposit","multiple":false,"typeClass":"primitive","value":"2015-11-10"}]}},"files":[{"label":"Labcode 12- HIV neutralization Protocol Recombinant Viruses in HEK-293T.pdf","restricted":false,"version":1,"datasetVersionId":77868,"dataFile":{"id":2723743,"persistentId":"doi:10.7910/DVN/SNCLKL/UJFNEU","pidURL":"https://doi.org/10.7910/DVN/SNCLKL/UJFNEU","filename":"Labcode 12- HIV neutralization Protocol Recombinant Viruses in HEK-293T.pdf","contentType":"application/pdf","filesize":165257,"storageIdentifier":"s3://dvn-cloud:150f0feb82a-7fd4a09589fe","rootDataFileId":-1,"md5":"d2915953550cc40875aedbc4a9869c46","checksum":{"type":"MD5","value":"d2915953550cc40875aedbc4a9869c46"}}}]}}}